Juan-Pablo Mas

Juan-Pablo Mas is a Partner at Action Potential Venture Capital since August 2014, focusing on investments in Bioelectronic Medicines, Precision Diagnostics, and Computational Biology. In addition to this role, Juan-Pablo serves as a Board Member for several companies, including Onc.AI, Exo Imaging, Inc., Saluda Medical, Presidio Medical, Inc., SetPoint Medical, Gradient Denervation Technologies, and Cala Health. Additionally, Juan-Pablo is a Board Observer for Neuspera Medical Inc. and is involved with the Translational Oversight Committee at the Stanford Wu Tsai Neurosciences Institute. Juan-Pablo holds an MBA from Stanford University Graduate School of Business, an MS in Electrical Engineering from Stanford University, and a BS in Electrical Engineering with a Mathematics Minor from the University of Massachusetts Amherst.